NCT02074995 Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects Status TERMINATED Phase PHASE2
NCT02074982 Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT02069886 Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia Status WITHDRAWN Phase PHASE4
NCT02069093 Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02064868 Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients Status TERMINATED Phase PHASE3
NCT02062892 Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients Status WITHDRAWN Phase PHASE4
NCT02062645 Study of Efficacy and Safety of CVAA489 in Hypertensive Patients Status COMPLETED Phase PHASE4
NCT02060383 Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Status COMPLETED Phase PHASE4
NCT02059291 Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers Status COMPLETED Phase PHASE3
NCT02058381 A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02058108 Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection Status TERMINATED Phase PHASE3
NCT02055352 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Status COMPLETED Phase PHASE4
NCT02052687 A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453 Status COMPLETED Phase PHASE1
NCT02051751 A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer Status COMPLETED Phase PHASE1
NCT02049450 Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia. Status COMPLETED Phase PHASE2
NCT02048787 Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment. Status COMPLETED Phase PHASE1
NCT02047656 To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension Status TERMINATED Phase PHASE1
NCT02044848 Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT02042014 Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan Status COMPLETED Phase PHASE3